Trident Lifeline has informed that the Trident Lifeline has made an additional investment in Tns Pharma, its subsidiary, by acquiring 10,20,000 equity shares. Consequently, the total shareholding percentage in the subsidiary remains unchanged at 51%.
The above information is a part of company’s filings submitted to BSE.